Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2020

Pharma News, 2020

Dementia gene raises risk of severe COVID-19
Dementia gene raises risk of severe COVID-19
Having a faulty gene linked to dementia doubles the risk of developing severe COVID-19, according to a large-scale study.
U.S. FDA finds high levels of carcinogen in diabetes drug metformin
U.S. FDA finds high levels of carcinogen in diabetes drug metformin
(Reuters) - The U.
Antibody drug tech firm AbCellera raises $105 million as it works on COVID-19
Antibody drug tech firm AbCellera raises $105 million as it works on COVID-19
Canadian drug discovery technology company AbCellera, which analyzes and identifies antibodies for pharmaceutical companies working on a coronavirus treatment and other medicines, said on Wednesday it...
Novo Nordisk launches social responsibility strategy for diabetes
Novo Nordisk launches social responsibility strategy for diabetes
Novo Nordisk has launch a new social responsibility strategy Defeat Diabetes, which introduces new long-term ambitions to provide access to affordable diabetes care to vulnerable patients in every cou...
Pharma exports a rare bright spot for Singapore economy as pandemic drives demand
Pharma exports a rare bright spot for Singapore economy as pandemic drives demand
SINGAPORE, May 27 (Reuters) - Singapore’s exports of pharmaceutical products have surged this year as the coronavirus pandemic prompts worldwide stockpiling of drug ingredients, providing a ...
FDA Approves First Treatment for a Form of Bladder Dysfunction in Pediatric Patients as Young as 2 Years of Age
FDA Approves First Treatment for a Form of Bladder Dysfunction in Pediatric Patients as Young as 2 Years of Age
The U.
WHO pauses hydroxycholoroquine arm in COVID-19 trial
WHO pauses hydroxycholoroquine arm in COVID-19 trial
The World Health Organisation has announced a temporary pause on a clinical trial arm testing hydroxycholoroquine on safety concerns.
New US approval for Takeda’s Alunbrig
New US approval for Takeda’s Alunbrig
US regulators have expanded the scope of Takeda's Alunbrig (brigatinib) to include first-line treatment of adults with anaplastic lymphoma kinase-positive (ALK+) metastatic non...
Sanofi to sell stake in Regeneron
Sanofi to sell stake in Regeneron
Sanofi has revealed its intent to sell its equity investment in Regeneron through a registered public offering and related share repurchase by the firm.
Arginine is a potential disease-modifying drug for polyglutamine disease
Arginine is a potential disease-modifying drug for polyglutamine disease
Familial spinocerebellar ataxia (SCA), Huntington disease, and spinal and bulbar muscular atrophy are inherited neurodegenerative diseases.
Sunovion Announces U.S. FDA Approval of KYNMOBI™ (apomorphine hydrochloride) Sublingual Film for the Treatment of Parkinson’s Disease OFF Episodes
Sunovion Announces U.S. FDA Approval of KYNMOBI™ (apomorphine hydrochloride) Sublingual Film for the Treatment of Parkinson’s Disease OFF Episodes
MARLBOROUGH, Mass.
First signs if a COVID-19 vaccine works possible in autumn: GAVI
First signs if a COVID-19 vaccine works possible in autumn: GAVI
ZURICH (Reuters) - First indications of the effectiveness of a potential vaccine against coronavirus may be available in the autumn, the head of the GAVI vaccine alliance told a Swiss newspape...
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand